• News
  • Press Releases
About Publications Sign in Subscribe
  • Pharmaceuticals
  • Medical Tech
  • Bioinformatics
  • Agriculture & Environmental
  • Industrial Biotech
  • Regenerative Medicine
  • Synthetic Biology
  • Genomics
  • Genetic Engineering & Gene Editing
Former Google AI Expert's Biotech Start-Up Raises $100 Million for AI-Driven Drug Innovation
Bioinformatics
, Pharmaceuticals
Muhammad 1 min read Sep 13, 2023

Former Google AI Expert's Biotech Start-Up Raises $100 Million for AI-Driven Drug Innovation

Inceptive, founded by a former Google AI expert, secures $100M in funding from investors like Nvidia and Andreessen Horowitz to advance AI-driven biotech initiatives

Top Stories

Roche to Acquire Carmot Therapeutics in a $3.1 Billion Deal

Roche to acquire Carmot Therapeutics for $3.1B, gaining access to innovative obesity and diabetes treatments. The deal includes clinical-stage assets with potential for standalone and combination therapies. Expected to close in Q1 2024, pending regulatory approval.
Pharmaceuticals
Medical Tech
Dec 5, 2023

Samsung Biologics and VC Firm Kurma Partners Announce Biologics Manufacturing Partnership for Kurma's Portfolio Companies

Samsung Biologics & Kurma Partners team up for biologics development & manufacturing, empowering startups in Kurma's portfolio with tailored CMC services & global expertise. A strategic partnership driving biopharmaceutical innovation.
Medical Tech
Pharmaceuticals
Oct 24, 2023

Edesa Biotech Secures C$23 Million Canadian Govt. Funding to Accelerate Breakthrough Immune Treatment

Edesa Biotech secures C$23 million in government funding for Phase 3 clinical study of EB05, a pioneering immune therapy, as announced in their press release. The funding reinforces their commitment to advancing healthcare innovation.
Pharmaceuticals
Oct 13, 2023

Latest

Saudi Arabia and UK Forge Healthcare Partnership: Sign MoC for Collaborative Expertise Exchange

London, June 15, 2023: The Health Minister of Saudi Arabia, Fahad Al-Jalajel and the Secretary of State for Health and Social Care in the UK, Steve Barcly have officially entered into a Memorandum of Cooperation (MoC) between their respective ministries, solidifying a formal agreement for joint efforts to strengthen collaboration
Admin 1 min read Jun 20, 2023

Syncona's New Venture Beacon Therapeutics Set to Revolutionise Gene Therapy Landscape

12 June 2023: Syncona Ltd has introduced its third gene therapy company Beacon Therapeutics Holdings Ltd. Beacon Therapeutics will bring together two preclinical ophthalmologic programs owned by Syncona with Applied Genetic Technologies Corp's (AGTC's) advanced X-linked retinitis pigmentosa (XLRP) program. Syncona has allocated £75 million to Beacon, which includes the
Genomics
Admin 2 min read Jun 16, 2023

VaxEquity Awarded A £700k UK Grant to Boost RNA Manufacturing Capacity

5 June 2023: RNA vaccine developer VaxEquity, in partnership with the Centre for Process Innovation (CPI), has successfully obtained a £700k grant from Innovate UK, an innovation agency based in the UK. This substantial funding will support a joint initiative aimed at progressing the manufacturing methods for RNA vaccines and
Admin 1 min read Jun 12, 2023

Samsung Biologics Enters Into Major Manufacturing Contract Worth $400 Million+ With Pfizer

June 8, 2023: South Korea-based Samsung Biologics has secured a lucrative contract worth $411 million from pharmaceutical powerhouse Pfizer to produce biosimilars for it. As part of this agreement, Samsung will provide increased manufacturing capabilities to accommodate the production of a diverse range of biosimilars, including those related to oncology,
Medical Tech
Pharmaceuticals
Admin 1 min read Jun 9, 2023

UK’s Revolutionary Intracellular Drug Delivery Centre To Facilitate RNA Development

01 June 2023: A novel intracellular drug delivery centre is set to be established in the United Kingdom with the aim of providing extensive support for the advancement of ribonucleic acid (RNA) vaccines and therapeutics, as well as facilitating the progress of innovative drug delivery technologies. The UK intracellular drug
Medical Tech
Pharmaceuticals
Admin 1 min read Jun 6, 2023

3M Pledges Nearly £120 Million Investment in Biopharma Filtration Technology Advancements

31 May, 2023: 3M, a company known for its expertise in industrial equipment manufacturing, intends to allocate £120 million to enhance its capacities in order to provide greater assistance to the rapidly expanding field of biotech manufacturing. The investment will involve enhancing facilities and equipment, along with the establishment of
Medical Tech
Pharmaceuticals
Admin 1 min read Jun 2, 2023

Exploring The Major MedTech Trends Reshaping The Global Healthcare System

In the vast realm of healthcare, technology has emerged as a driving force, catalysing the greatest breakthroughs and transforming the way we prevent, diagnose, and treat diseases. With each passing year, innovations in medical technology continue to push the boundaries of what was once considered unimaginable. From artificial intelligence to
Bioinformatics
Medical Tech
Admin 4 min read Jun 2, 2023
Newer Posts
Older Posts

Most Popular

Samsung Biologics and VC Firm Kurma Partners Announce Biologics Manufacturing Partnership for Kurma's Portfolio Companies

Samsung Biologics and VC Firm Kurma Partners Announce Biologics Manufacturing Partnership for Kurma's Portfolio Companies

Pfizer-Backed VitaDAO Community Approves Launch and Financing of Its First Longevity Biotech Company

Pfizer-Backed VitaDAO Community Approves Launch and Financing of Its First Longevity Biotech Company

2023 Nobel Prize in Physiology or Medicine Awarded to Dr. Karikó and Dr. Weissman for Contributions to mRNA-based COVID-19 Vaccines

2023 Nobel Prize in Physiology or Medicine Awarded to Dr. Karikó and Dr. Weissman for Contributions to mRNA-based COVID-19 Vaccines

Henlius Biotech's HANSIZHUANG (Serplulimab) Approved for Treatment of Esophageal Cancer (ESCC)

Henlius Biotech's HANSIZHUANG (Serplulimab) Approved for Treatment of Esophageal Cancer (ESCC)

Elon Musk's Neurotechnology Startup to Initiate Human Trial For Brain Implants

Elon Musk's Neurotechnology Startup to Initiate Human Trial For Brain Implants

Stay Informed with the Latest Industry Insights Tailored to Your Preferences.

Don't miss out on the latest news. Sign up now to get access to the library of members-only articles.
Industry Inscript Get updates on social media
Sitemap
  • Sign up
Reach out to our audience
  • Post a press release
Valiant Industry Inscript is a subsidiary of Valiant and Company Ltd.
2025 © Industry Inscript . All Rights Reserved
Privacy Policy